Psychiatrists call it the "trial and error factor": when they set out to prescribe an antidepressant, they have no clinically proven way of knowing which one to ...

Alexis Garcia, PharmD, senior director of business development at Tabula Rasa HealthCare, outlines how cytochrome P450 enzymes can impact medication efficacy in patients taking multiple drugs. So the ...

Aim: The present study aimed to investigate the human genetic diversity of the CYP450 superfamily in order to identify functional interethnic differences and analyze the role of CYP450 enzymes in ...

September 25, 2012 (Phoenix, Arizona) — Patients with chronic pain who require high doses of opioids to achieve pain relief show exceptionally high rates of defects of the cytochrome P450 (CYP450) ...

Phase I study of docetaxel and temsirolimus in refractory solid tumors. Background: Interactions of cytochrome P450 (CYP), especially CYP3A4, between chemotherapy agents and other xenobiotics can ...

Pharmacokinetic drug-drug interactions (DDIs) involving opioid analgesics can be problematic. Opioids are widely used, have a narrow therapeutic index, and can be associated with severe toxicity. The ...

THERE ARE MANY REASONS that promising drugs wash out during pharmaceutical development, and one of them is cytochrome P450. A set of enzymes mostly produced in the liver, CYP450, as it is commonly ...

The cytochrome P450 enzymes constitute a diverse superfamily of haem-containing proteins that catalyse key oxidative reactions in steroid biosynthesis. In the steroidogenic pathway, these enzymes ...

The company said it is believed to be the first clinical lab to offer testing for variants in all cytochrome P450 genes known to influence the CYP450 enzyme system, which affects the metabolism of ...